Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study - Wikidata - awgldk - TriplyDB

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study

http://www.wikidata.org/entity/Q37130193

about

Serum correlates of the placebo effect in irritable bowel syndrome Probiotics and irritable bowel syndrome The quest for biomarkers in IBS-where should it lead us?Understanding gastrointestinal distress: a framework for clinical practice.Pilot study of Biomarkers for predicting effectiveness of ramosetron in diarrhea-predominant irritable bowel syndrome: expression of S100A10 and polymorphisms of TPH1 Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis Brain-Gut Interactions in IBS Anticipation of thermal pain in diverticular disease.Abdominal Pain, the Adolescent and Altered Brain Structure and Function.The HTR3A polymorphism c. -42C>T is associated with amygdala responsiveness in patients with irritable bowel syndrome.Challenges to the therapeutic pipeline for irritable bowel syndrome: end points and regulatory hurdles.Serotonin in the gastrointestinal tract.Gastrointestinal and psychological mediators of health-related quality of life in IBS and IBD: a structural equation modeling analysis.Serotonin and molecular neuroimaging in humans using PET.

P2860

Q24598909-0B418EF5-1480-4C77-9F0B-7E4876D624EE Q24616349-C30FC4BB-4FC3-4760-B15B-E60D2941699C Q27024239-8ABD244D-6D42-4978-A229-3CC10F3F7A82 Q34764170-5E229314-12DC-462E-9479-65743D9747D4 Q34848481-0BEA9444-1FAE-4376-BC88-BAD7D83A21AB Q36050769-DE5DF1D1-0EED-493F-853F-280E3BA32796 Q36076024-28D5D3D5-B8CE-4148-9593-C10A92BB6692 Q36933771-FB9392D7-BA83-45D4-93AB-A430BDDB4756 Q36951318-1F451169-BE88-4299-A4D4-C4171B444402 Q37134075-B6604933-FF62-402C-9F74-8EDCE2FA1557 Q37164063-D9EC91BC-128D-4CD9-86D6-A327C9210B37 Q37223378-EF169133-4E2A-4172-B748-CBB9011CD22E Q37374090-924CA49D-720B-41F9-BB3D-50D9EAF0BD26 Q37938794-77A95F4E-393A-4054-9570-494E87C2F0B4

P2860

Neural and psychological predictors of treatment response in irritable bowel syndrome patients with a 5-HT3 receptor antagonist: a pilot study

http://www.wikidata.org/entity/Q37130193

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on August 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Neural and psychological predi ...... ptor antagonist: a pilot study

@en

Neural and psychological predi ...... tor antagonist: a pilot study.

@nl

type

label

Neural and psychological predi ...... ptor antagonist: a pilot study

@en

Neural and psychological predi ...... tor antagonist: a pilot study.

@nl

prefLabel

Neural and psychological predi ...... ptor antagonist: a pilot study

@en

Neural and psychological predi ...... tor antagonist: a pilot study.

@nl

P1433

Q37130193-90EE5210-9074-466A-A316-5B1DFA171EA2

P1476

Q37130193-5B541D44-929E-402F-B68A-75E7EF270640

P2093

Q37130193-02B9A4E2-613F-46AA-99DA-19196B711573

Q37130193-1B477B09-64F0-4200-A6B8-843C41ADFD61

Q37130193-6AD66F1A-4AFB-4379-9B97-35D9C56A213A

Q37130193-8EF2B68E-2310-4050-BC70-E08300A68825

Q37130193-A5E380B4-5E96-4C0A-B532-E7DF48809DC0

Q37130193-B67C7FC7-FC2E-46C0-A870-FE8A982B147A

Q37130193-EF215B2E-3374-4157-B980-46B0E882BEFE

Q37130193-F630C2DA-954E-4B18-B0E0-80E6DC029DDB

Q37130193-FFC5C1C1-79B9-459D-B61F-F2A33A3C5957

P2860

Q37130193-022A5180-CC90-4AC4-89D2-C47325117242

Q37130193-05AA474C-8711-45C3-8A67-44A8C43850DA

Q37130193-06DCF794-75B1-4BB5-8CC7-E4E9D1999398

Q37130193-12738ADB-90E0-4B2D-A046-4FC58C65ADB6

Q37130193-12FD3A95-355B-437A-8205-C4FF4689D7D6

Q37130193-172BF30C-064A-4276-8AB9-E00912FCC8FB

Q37130193-1A832CD2-CA58-4B5C-BFDA-D0CFA83BE185

Q37130193-1AB64ECB-B29D-4494-B8F8-CF65C561BE67

Q37130193-1AF99F81-A766-4B1F-B603-053E26588121

Q37130193-298444DC-41DA-448C-89F7-D02551F1A134

P304

Q37130193-F3320F58-4744-4E19-8B09-D8F1CE4ACB6F

P31

Q37130193-A4FED06D-5AB5-4D2E-A98C-8D976D56B5B4

P356

Q37130193-3A2EF343-1873-4CEF-82AE-BFDE0D1D2CCD

P407

Q37130193-E51F2545-3E11-47AD-93F5-A60C2FF5571B

P433

Q37130193-3A02A748-E08A-4922-A9F5-43956AF5100D

P478

Q37130193-2A6C5FF6-67D7-4B6C-AEFE-5F40764D81F2

P577

Q37130193-30C912AD-76D8-423E-82F9-629582100920

P5875

Q37130193-766CCA0E-AA44-40C6-A16E-85299E11B91E

P698

Q37130193-4FD69ACB-CB54-4925-8E42-F360E14B8A0C

P932

Q37130193-14AC03B3-EED3-4FA5-BEB9-8AEEFC8C0D4E

P356

J.1365-2036.2008.03721.X

P1433

Alimentary Pharmacology & Therapeutics

P1476

Neural and psychological predi ...... ptor antagonist: a pilot study

@en

P2093

B D Naliboff

http://www.w3.org/2001/XMLSchema#string

B Suyenobu

http://www.w3.org/2001/XMLSchema#string

E A Mayer

http://www.w3.org/2001/XMLSchema#string

J M Jarcho

http://www.w3.org/2001/XMLSchema#string

L Chang

http://www.w3.org/2001/XMLSchema#string

M A Mandelkern

http://www.w3.org/2001/XMLSchema#string

M Berman

http://www.w3.org/2001/XMLSchema#string

M D Lieberman

http://www.w3.org/2001/XMLSchema#string

V Z Ameen

http://www.w3.org/2001/XMLSchema#string

P2860

Functional bowel disorders and functional abdominal pain

The burden of illness of irritable bowel syndrome: current challenges and hope for the future

Evidence-based and intuition-based self-knowledge: an FMRI study.

Incidence of ischemic colitis and serious complications of constipation among patients using alosetron: systematic review of clinical trials and post-marketing surveillance data.

Neuroimaging of the brain-gut axis: from basic understanding to treatment of functional GI disorders.

Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders.

The placebo effect in irritable bowel syndrome trials: a meta-analysis.

Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.

Alosetron and irritable bowel syndrome.

AGA technical review on irritable bowel syndrome.

P304

344-352

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2036.2008.03721.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P577

2008-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5422774

http://www.w3.org/2001/XMLSchema#string

P698

19086332

http://www.w3.org/2001/XMLSchema#string

P932

2656431

http://www.w3.org/2001/XMLSchema#string